TN2018000135A1 - Extraction and exploitation of beta keratin, beta keratin and its derivatives. - Google Patents
Extraction and exploitation of beta keratin, beta keratin and its derivatives.Info
- Publication number
- TN2018000135A1 TN2018000135A1 TNP/2018/000135A TN2018000135A TN2018000135A1 TN 2018000135 A1 TN2018000135 A1 TN 2018000135A1 TN 2018000135 A TN2018000135 A TN 2018000135A TN 2018000135 A1 TN2018000135 A1 TN 2018000135A1
- Authority
- TN
- Tunisia
- Prior art keywords
- keratin
- extraction
- beta keratin
- beta
- protein
- Prior art date
Links
- 108010049062 beta-Keratins Proteins 0.000 title abstract 4
- 238000000605 extraction Methods 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108010076876 Keratins Proteins 0.000 abstract 1
- 102000011782 Keratins Human genes 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000000834 fixative Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Abstract
L'extraction innovante et le nouveau solvant inventé ont permis l'extraction de la protéine de la kératine béta en toute sa conformité et sa stabilité. Cette protéine est favorisée par rapport la kératine alpha, pour l'utilisation humaine, car elle ne nécessite pas l'addition des produits chimique et des fixateurs pour qu'elle puisse donner un effet. La kératine béta est destinée pour l'industrie pharmaceutique, parapharmaceutique et cosmétique. La technique et la protéine sont utilisées par le laboratoire d'industrie pharmaceutique et parapharmaceutique, en exclusivité, Aujourd'hui.The innovative extraction and the new invented solvent allowed the extraction of the protein from beta keratin in all its conformity and stability. This protein is favored over alpha keratin, for human use, as it does not require the addition of chemicals and fixatives for it to give an effect. Beta keratin is intended for the pharmaceutical, parapharmaceutical and cosmetic industries. The technique and the protein are used by the pharmaceutical and parapharmaceutical industry laboratory, exclusively, Today.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TNP/2018/000135A TN2018000135A1 (en) | 2018-04-24 | 2018-04-24 | Extraction and exploitation of beta keratin, beta keratin and its derivatives. |
| PCT/TN2019/000004 WO2019209188A1 (en) | 2018-04-24 | 2019-02-19 | Extraction and use of beta-keratin, beta-keratin and the derivatives thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TNP/2018/000135A TN2018000135A1 (en) | 2018-04-24 | 2018-04-24 | Extraction and exploitation of beta keratin, beta keratin and its derivatives. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2018000135A1 true TN2018000135A1 (en) | 2019-10-04 |
Family
ID=66530404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP/2018/000135A TN2018000135A1 (en) | 2018-04-24 | 2018-04-24 | Extraction and exploitation of beta keratin, beta keratin and its derivatives. |
Country Status (2)
| Country | Link |
|---|---|
| TN (1) | TN2018000135A1 (en) |
| WO (1) | WO2019209188A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4532528A1 (en) * | 2022-05-27 | 2025-04-09 | Stimlabs LLC | Keratin protein extracts, compositions, methods and uses thereof |
| FR3161359A1 (en) | 2024-04-19 | 2025-10-24 | Hkvor | PROCESS FOR EXTRACTION OF HUMAN KERATIN FROM HAIR |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2487197A2 (en) * | 1979-05-11 | 1982-01-29 | Thomas Andre | Extraction of glyco:proteins and muco:polysaccharide(s) - by macerating animal tissue in a slightly alkaline buffer |
| MXPA05005597A (en) * | 2002-11-28 | 2005-07-26 | Keratec Ltd | Personal care formulations containing keratin. |
| EP3412683B1 (en) * | 2011-08-17 | 2022-02-09 | KeraNetics, Inc. | Methods for extracting keratin proteins |
-
2018
- 2018-04-24 TN TNP/2018/000135A patent/TN2018000135A1/en unknown
-
2019
- 2019-02-19 WO PCT/TN2019/000004 patent/WO2019209188A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019209188A9 (en) | 2019-12-05 |
| WO2019209188A1 (en) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020005645A2 (en) | Trispecific proteins and methods of use | |
| EA202091711A1 (en) | HETEROCYCLYLAMINE-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEINKINASE | |
| BR112018013827A2 (en) | 5'-nucleotidase modulators, ecto and use thereof | |
| MX2021007570A (en) | ARNI AGENT COMPOSITIONS OF AMYLOID PRECURSOR PROTEIN (APP) AND METHODS OF USE THEREOF. | |
| EA201990221A1 (en) | 1,3-DIHYDROXIPHENYL DERIVATIVES APPLICABLE AS IMMUNOMODULATORS | |
| BR112019023856A2 (en) | triespecific proteins targeting msln and methods of use | |
| CL2018003178A1 (en) | Pharmaceutical composition | |
| TN2018000135A1 (en) | Extraction and exploitation of beta keratin, beta keratin and its derivatives. | |
| EA202091318A1 (en) | A PREPARATION CONTAINING GROUP B ADENOVIRUS | |
| EA201890198A1 (en) | NEW PROTEINS SPECIFIC FOR THE LAG-3 | |
| CL2019003404A1 (en) | Isolated tumor associated peptide (tumap); nucleic acid; expression vector; recombinant host cell comprising the peptide; method of producing the peptide; use to prepare a rare useful drug to treat cancer; pharmaceutical kit. (divisional application 201702407) | |
| EA201991951A1 (en) | LOW-VISCOUS HIGH-CONCENTRATED COMPOSITIONS BASED ON EVOLOCUMABA AND METHODS FOR PRODUCING THEM | |
| EP4553065A3 (en) | Novel compounds for treating mitochondrial disease | |
| MX2020010178A (en) | HAIR STYLING COMPOSITIONS COMPRISING POLYGALACTOMANS AND A METHOD FOR USE THEREOF. | |
| MA46548A (en) | FSH FOR INFERTILITY TREATMENT | |
| EA202193245A1 (en) | LIQUID COMPOSITION OF BOTULINIC TOXIN FOR THE TREATMENT OF EYEBROW WRINKLES AND LATERAL PERIORBITAL WRINKLES FROM MODERATE TO STRONGLY PROGRESSED | |
| EP3957314A4 (en) | USE OF EXTRACT FROM RABBIT SKIN INFLATED BY VACCINE VIRUS IN THE TREATMENT OF DAMAGE TO THE HEMATOPOIETIC SYSTEM | |
| EA202192008A1 (en) | LILRB3-BINDING MOLECULES AND VARIANTS OF THEIR APPLICATION | |
| BR112023022367A2 (en) | ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF | |
| CO2018011420A2 (en) | Liquid phosphaplatin formulations | |
| EP4157320A4 (en) | TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR THERAPEUTIC TARGETS FOR COVID-19 | |
| MY209375A (en) | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder | |
| EA202190766A1 (en) | IMMUNOMODULATORS, THEIR COMPOSITIONS AND METHODS OF APPLICATION | |
| MX2023004807A (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CELIACIA. | |
| EA202190014A1 (en) | COMPOSITION CONTAINING GLYCIRRISIN AND ITS COSMETIC PRODUCT AND PHARMACEUTICAL APPLICATIONS |